Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Search Posts
Op-Eds
Europe’s REACH Exceeds Its Scientific Grasp
European regulatory officials have raised hostility to technological innovation to an art form. Their current medium of choice is the Precautionary Principle, which holds…
Op-Eds
Stockholm Syndrome
The Stockholm Convention on Persistent Organic Pollutants (POPs) is a United Nations Environment Programme Convention, which bans or regulates industrial chemicals and pesticides. The…
Op-Eds
Brussels’ Bad Science Will Cost the World Dear
Regulatory officials in the European Union seem to be ignorant of the rule of holes: when you are in one, stop digging. Numerous analyses…
Op-Eds
The Brundtland Legacy
The five-year tenure of Gro Harlem Brundtland as head of the World Health Organisation (WHO) has just come to an end. She leaves behind…
USA Today
Republican Senator, Auto-Safety Advocate Form Unlikely Alliance
News Release
Drug Re-Importation Bill: Cheaper Drugs Today, But Fewer Medicines Tomorrow
Contact for Interviews: Richard Morrison, 202.331.2273 or Jody Clarke, 202.331.2252 Washington, D.C., July 25, 2003—The vote by the U.S. House to allow the re-importation of…